Diagnosis Disclosure Process in Patients With Malignant Brain Tumors

Conspiracy of Silence in Head and Neck Cancer Diagnosis: A Scoping Review

Cancer disclosure represents a complex healthcare dynamic. Physicians or caregivers may be prompted to withhold diagnosis information from patients. This study aims to comprehensively map and synthesize available evidence about diagnosis nondisclosure regarding head and neck cancer (HNC) patients. Following the Joanna Briggs Institute guidelines, a scoping review was conducted across major databases without period restriction, yielding 9238 publications. After screening and selection, a descriptive synthesis was conducted. Sixteen studies were included, primarily conducted in academic settings (75%) from Europe and Asia, with a total population of 662 patients predominantly diagnosed with brain, oral, pharyngeal, or laryngeal tumors. Remarkably, 22.51% of patients were unaware of their diagnosis. Although physicians were the main source of diagnostic information (35%), they reported to often use vague terms to convey malignancy. Additionally, 13.29% of patients were aware of their diagnosis from sources other than doctors or caregivers. Caregivers (55%) supported diagnosis concealment, and physicians tended to respect family wishes. A high diagnosis-to-death interval, education, and age significantly influenced diagnosis disclosure. HNC patients expressed a desire for personalized open communication. Multiple factors influenced the decision on diagnosis disclosure. Current evidence on this topic varies significantly, and there is limited research on the consequences of nondisclosure. These findings reflect the underestimation of the patients' outlook in the diagnosis process and highlight the need for further research, aiming to establish open communication and patient autonomy during the oncological journey.

Preoperative Surgical Fear and Related Factors of Patients Undergoing Brain Tumor Surgery

PURPOSE

Patients with brain tumors may experience preoperative fear due to various reasons such as obscurity, pain, and loss of function. This study was carried out to reveal the pre-operative fear levels of patients undergoing brain tumor surgery.

DESIGN

This descriptive and cross-sectional study was completed with 144 patients.

METHODS

Data were obtained using patient identification forms and the Surgical Fear Questionnaire (SFQ). Descriptive statistics, independent t test, one-way Anova, Pearson correlation, and multiple regression analysis were used.

FINDINGS

The results revealed that the duration of preoperative hospital stay was 3.05 ± 2.26 days, the mean age of the patients was 51.44 ± 13.76 years, and more than half (54.1%) were male. The SFQ total and subscale mean scores of patients who are not working were higher (P < .05). The mean SFQ total and subscale mean scores of those aged 53 and over were lower. (P < .05). Duration of preoperative hospital stay, age, and female gender were statistically significant predictors of SFQ. Duration of preoperative hospital stay was responsible for 62.3% of the change in the SFQ, female gender was responsible for 17.6%, and age was responsible for 20.4%.

CONCLUSION

Understanding the risk factors for preoperative fear can help identify patients at risk. Factors that cause fear should be investigated and information deficiencies that increase the level of fear should be eliminated. It is recommended to use pharmacological and nonpharmacological methods in managing the fear of risk groups.

Diagnosis Disclosure: Patient Preferences and the Role of the Breast Nurse Navigator

BACKGROUND

Receiving a breast cancer diagnosis can be traumatic and anxiety-producing. The way the diagnosis is disclosed to patients can affect their experience.

OBJECTIVES

The aim of this article is to determine patient preferences for being informed of a breast cancer diagnosis and the breast nurse navigator (BNN) role during the diagnostic experience.

METHODS

A survey was mailed to 517 patients with breast cancer. Summary statistics were performed on 199 completed surveys.

FINDINGS

Patients preferred to hear their diagnosis in person. BNNs were more likely to provide the right amount of support and resources compared to other providers. Patients described the following preferences.

[Impact of driving restrictions disclosure on quality of life of patients with a glial tumor: A prospective study]

INTRODUCTION

Disclosure of driving restrictions on patients with glial tumors is a complex and difficult task. The difficulty of such task lies in the moral and ethical conflicts it generates for the patient on one hand and caregivers on the other. These aforementioned conflicts impinge upon the patient's quality of life which is one of the important aspects of neuro-oncologic care.

PATIENTS AND METHOD

In a prospective survey of 31 patients diagnosed with glial tumors, we studied how the patient perceived the disclosure of driving restrictions specifically the amount of retained information, and the level of distress.

RESULTS

It seems that patients fail to assess the juridical implications of driving restrictions. The impact on quality of life as well as psychological and social aspects of these restrictions must not be taken lightly especially in young patients with low-grade glioma who has a long life expectancy.

CONCLUSION

Therefore, we believe that planning a specific psychological and social accompaniment of the patient in relation to driving restrictions is an undeniable necessity.